Sign inGet started

ADELMAN BURT A

Insider CIK 1226283 · CATB Director · VERV Director · DYAX EVP; Chief Medical Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
VERV Verve Therapeutics, Inc. D To issuer deriv2025-07-252025-07-28136,139— $00SEC↗
VERV Verve Therapeutics, Inc. D To issuer deriv2025-07-252025-07-2843,198— $00SEC↗
VERV Verve Therapeutics, Inc. D To issuer deriv2025-07-252025-07-2842,200— $00SEC↗
VERV Verve Therapeutics, Inc. U Tender2025-07-252025-07-28428,326— $00SEC↗
VERV Verve Therapeutics, Inc. A Award deriv2025-06-052025-06-0642,200— $042,200SEC↗
VERV Verve Therapeutics, Inc. A Award deriv2024-06-262024-06-28136,139— $0136,139SEC↗
VERV Verve Therapeutics, Inc. A Award deriv2023-06-152023-06-2026,642— $026,642SEC↗
VERV Verve Therapeutics, Inc. A Award deriv2022-06-092022-06-1315,500— $015,500SEC↗
VERV Verve Therapeutics, Inc. P Buy2022-05-122022-05-1310,000$12.15 $121.5K18,700SEC↗
VERV Verve Therapeutics, Inc. P Buy2022-03-152022-03-174,000$21.38 $85.5K8,700SEC↗
VERV Verve Therapeutics, Inc. P Buy2021-12-022021-12-064,700$31.34 $147.3K4,700SEC↗
CATB CATABASIS PHARMACEUTICALS A Award deriv2020-06-112020-06-127,500— $07,500SEC↗
CATB CATABASIS PHARMACEUTICALS A Award deriv2019-06-042019-06-057,500— $07,500SEC↗
CATB CATABASIS PHARMACEUTICALS A Award deriv2018-06-072018-06-0714,000— $014,000SEC↗
CATB CATABASIS PHARMACEUTICALS A Award deriv2017-07-272017-07-286,500— $06,500SEC↗
CATB CATABASIS PHARMACEUTICALS A Award deriv2016-04-052016-04-0713,000— $013,000SEC↗
DYAX DYAX CORP D To issuer deriv2016-01-222016-01-22225,000— $00SEC↗
DYAX DYAX CORP D To issuer deriv2016-01-222016-01-22500,000— $00SEC↗
DYAX DYAX CORP D To issuer deriv2016-01-222016-01-22235,000— $00SEC↗
DYAX DYAX CORP D To issuer deriv2016-01-222016-01-2268,542— $00SEC↗
DYAX DYAX CORP D To issuer deriv2016-01-222016-01-22233,749— $00SEC↗
DYAX DYAX CORP D To issuer deriv2016-01-222016-01-2242,232— $00SEC↗
DYAX DYAX CORP D To issuer2016-01-222016-01-22208,602— $00SEC↗
DYAX DYAX CORP M Exercise deriv2016-01-132016-01-15140,268— $042,232SEC↗
DYAX DYAX CORP M Exercise deriv2016-01-132016-01-151,458— $068,542SEC↗
DYAX DYAX CORP M Exercise deriv2016-01-132016-01-151,251— $0233,749SEC↗
DYAX DYAX CORP M Exercise2016-01-132016-01-151,251$3.00 $3.8K208,602SEC↗
DYAX DYAX CORP M Exercise2016-01-132016-01-151,458$2.29 $3.3K207,351SEC↗
DYAX DYAX CORP M Exercise2016-01-132016-01-15140,268$1.48 $207.6K205,893SEC↗
DYAX DYAX CORP M Exercise deriv2015-12-222015-12-2210,000— $0182,500SEC↗
DYAX DYAX CORP M Exercise2015-12-222015-12-2210,000$1.48 $14.8K65,625SEC↗
DYAX DYAX CORP M Exercise deriv2015-12-172015-12-1827,500— $0192,500SEC↗
DYAX DYAX CORP M Exercise2015-12-172015-12-1827,500$1.48 $40.7K55,625SEC↗
DYAX DYAX CORP S Sale2015-03-052015-03-069,375$15.66 $146.8K28,125SEC↗
DYAX DYAX CORP A Award deriv2015-02-182015-02-20500,000— $0500,000SEC↗
DYAX DYAX CORP M Exercise deriv2015-01-022015-01-0575,000— $0220,000SEC↗
DYAX DYAX CORP M Exercise2015-01-022015-01-0575,000$1.48 $111.0K112,500SEC↗
DYAX DYAX CORP S Sale2015-01-022015-01-0575,000$14.05 $1.05M37,500SEC↗
DYAX DYAX CORP M Exercise deriv2014-03-032014-03-0355,000— $0295,000SEC↗
DYAX DYAX CORP S Sale2014-03-032014-03-0355,000$9.68 $532.4K37,500SEC↗
DYAX DYAX CORP M Exercise2014-03-032014-03-0355,000$1.48 $81.4K92,500SEC↗
DYAX DYAX CORP A Award deriv2014-02-272014-03-03225,000— $0225,000SEC↗
DYAX DYAX CORP A Award2014-02-272014-03-0337,500$10.20 $382.5K37,500SEC↗
DYAX DYAX CORP A Award deriv2013-04-012013-04-01235,000— $0235,000SEC↗
DYAX DYAX CORP A Award deriv2013-02-072013-02-11235,000— $0235,000SEC↗
DYAX DYAX CORP A Award deriv2012-10-102012-10-1270,000— $070,000SEC↗